<PAGE>
As filed with the Securities and Exchange Commission on September 13, 2000.
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 13 , 2000 (September 11, 2000)
MEDAREX, INC.
(Exact name of registrant as specified in its charter)
New Jersey 0-19312 22-2822175
(State of other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
707 State Road, Ste. 206, Princeton, N.J. 08540-1437
(Address of Principal Executive Offices)
Registrant's telephone number, including area code: (609) 430-2880
Not Applicable
(Former name or former address, if changed since last report)
<PAGE>
MEDAREX, INC.
TABLE OF CONTENTS
FOR
CURRENT REPORT ON FORM 8-K
Item 5. Other Events..................................................... 3
Item 7. Financial Statements and Exhibits................................ 4
Signature................................................................... 5
2
<PAGE>
Item 5. Other Events.
On September 11, 2000, Genmab A/S, a corporation organized
under the laws of the Kingdom of Denmark ("Genmab"), announced its intention to
seek listings on the Copenhagen and Frankfurt stock exchanges in October 2000 by
means of a global offering of ordinary shares. As of the date of this report,
Medarex, Inc. owns approximately 46% of Genmab.
Genmab has represented that the securities to be offered by it
and referred to herein have not been and will not be registered under the
Securities Act 1933, as amended, and may not be offered or sold in the United
States or to or for the benefit of United States persons absent registration or
pursuant to an available exemption from registration.
Item 7. Financial Statements and Exhibits.
(c) Exhibits. The following material is filed as an
exhibit to this Current Report on Form 8-K: None
3
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
MEDAREX, INC.
Registrant
Date: September 13, 2000 By: /s/ W. Bradford Middlekauff
----------------------------
W. Bradford Middlekauff
Vice President, Secretary and
General Counsel
4
